Menu
GeneBe

CABP4

calcium binding protein 4, the group of EF-hand domain containing

Basic information

Region (hg38): 11:67452405-67461752

Links

ENSG00000175544NCBI:57010OMIM:608965HGNC:1386Uniprot:P57796AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • cone-rod synaptic disorder, congenital nonprogressive (Strong), mode of inheritance: AR
  • congenital stationary night blindness (Supportive), mode of inheritance: AD
  • autosomal dominant nocturnal frontal lobe epilepsy (Supportive), mode of inheritance: AD
  • cone-rod synaptic disorder, congenital nonprogressive (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Cone-rod synaptic disorder, congenital nonprogressiveARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingOphthalmologic16960802; 23714322

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CABP4 gene.

  • not provided (269 variants)
  • Cone-rod synaptic disorder, congenital nonprogressive (110 variants)
  • Congenital Stationary Night Blindness, Recessive (22 variants)
  • Inborn genetic diseases (22 variants)
  • not specified (4 variants)
  • Retinal dystrophy (3 variants)
  • Cone-rod dystrophy (2 variants)
  • Congenital stationary night blindness (1 variants)
  • Usher syndrome (1 variants)
  • Cone dystrophy (1 variants)
  • Achromatopsia (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CABP4 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
6
clinvar
45
clinvar
3
clinvar
54
missense
1
clinvar
1
clinvar
124
clinvar
7
clinvar
3
clinvar
136
nonsense
5
clinvar
2
clinvar
1
clinvar
8
start loss
0
frameshift
7
clinvar
2
clinvar
9
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
3
clinvar
3
clinvar
2
clinvar
8
splice region
6
6
5
17
non coding
1
clinvar
77
clinvar
19
clinvar
19
clinvar
116
Total 17 8 210 72 25

Highest pathogenic variant AF is 0.0000395

Variants in CABP4

This is a list of pathogenic ClinVar variants found in the CABP4 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
11-67452459-A-G not specified Uncertain significance (May 04, 2023)2533206
11-67452532-G-A not specified Uncertain significance (Sep 16, 2021)2357316
11-67452544-C-T Cone-rod synaptic disorder, congenital nonprogressive Benign (May 28, 2019)802691
11-67452545-A-T not specified Likely benign (Apr 11, 2023)2519515
11-67452564-G-A not specified Uncertain significance (Feb 06, 2023)2480630
11-67452668-C-G not specified Uncertain significance (Aug 04, 2021)2407519
11-67455134-A-C Benign (Jul 06, 2018)1259072
11-67455397-G-A Cone-rod synaptic disorder, congenital nonprogressive Uncertain significance (Jan 12, 2018)305638
11-67455427-A-G Uncertain significance (Apr 24, 2021)1390659
11-67455433-G-C Cone-rod synaptic disorder, congenital nonprogressive • Inborn genetic diseases Conflicting classifications of pathogenicity (Jan 05, 2024)879532
11-67455438-G-T Uncertain significance (Feb 19, 2022)1418547
11-67455444-G-C Uncertain significance (Jun 04, 2022)2038233
11-67455447-G-A Likely benign (Jun 09, 2021)1563022
11-67455459-A-G Likely benign (Jan 02, 2024)2105254
11-67455465-G-C Likely benign (Jan 18, 2024)1084483
11-67455469-A-G Uncertain significance (Feb 07, 2020)1009632
11-67455470-T-C Inborn genetic diseases Conflicting classifications of pathogenicity (Oct 12, 2022)1519143
11-67455473-G-C Benign (Dec 15, 2023)771570
11-67455475-C-T Uncertain significance (Jul 19, 2022)1017265
11-67455476-G-A Cone-rod synaptic disorder, congenital nonprogressive Benign (Jan 14, 2024)305639
11-67455482-A-G Uncertain significance (May 24, 2022)1998207
11-67455483-GC-G Retinal dystrophy • Cone-rod synaptic disorder, congenital nonprogressive Pathogenic/Likely pathogenic (Jun 01, 2021)866054
11-67455484-CC-A Cone-rod synaptic disorder, congenital nonprogressive Pathogenic (Jan 25, 2019)635475
11-67455487-C-G Uncertain significance (Mar 12, 2021)1428251
11-67455488-C-T Uncertain significance (Sep 12, 2022)1522473

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CABP4protein_codingprotein_codingENST00000325656 66823
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.68e-100.06241256900401257300.000159
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.5172081881.110.00001321749
Missense in Polyphen6152.6531.1585517
Synonymous-0.1888279.91.030.00000594583
Loss of Function-0.01721514.91.000.00000113124

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003260.000303
Ashkenazi Jewish0.0003180.000298
East Asian0.0002390.000163
Finnish0.000.00
European (Non-Finnish)0.0001560.000149
Middle Eastern0.0002390.000163
South Asian0.0002760.000261
Other0.0001640.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Involved in normal synaptic function through regulation of Ca(2+) influx and neurotransmitter release in photoreceptor synaptic terminals and in auditory transmission. Modulator of CACNA1D and CACNA1F, suppressing the calcium-dependent inactivation and shifting the activation range to more hyperpolarized voltages (By similarity). {ECO:0000250}.;
Disease
DISEASE: Cone-rod synaptic disorder, congenital non-progressive (CRSD) [MIM:610427]: A non-progressive retinal disorder characterized by stable low vision, nystagmus, photophobia, a normal or near-normal fundus appearance, and no night blindness. {ECO:0000269|PubMed:16960802}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.112

Intolerance Scores

loftool
0.896
rvis_EVS
-0.05
rvis_percentile_EVS
50.22

Haploinsufficiency Scores

pHI
0.182
hipred
N
hipred_score
0.146
ghis
0.559

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.726

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Cabp4
Phenotype
cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);

Gene ontology

Biological process
signal transduction;visual perception;phototransduction;photoreceptor cell morphogenesis;retinal cone cell development;retinal bipolar neuron differentiation
Cellular component
extracellular region;cytosol;terminal bouton;synapse
Molecular function
calcium channel regulator activity;calcium ion binding;ion channel binding